Showing results (1-10 of 163) with videos related to
Sort By:
Pageof 17
Science (New York, N.Y.)|July 12, 2014
A critical question for HIV vaccine development: which antibodies to induce?Susan Zolla-PaznerHuman Antibodies|May 25, 2006
Improving on nature: focusing the immune response on the V3 loopSusan Zolla-PaznerNature Reviews. Immunology|June 26, 2010
Structure-function relationships of HIV-1 envelope sequence-variable regions refocus vaccine designSusan Zolla-Pazner, Timothy CardozoMicrobiology Spectrum|June 25, 2015
Antibodies Targeting the Envelope of HIV-1Luzia M Mayr, Susan Zolla-PaznerJournal of Virology|June 14, 2019
Revisiting the Correlate of Reduced HIV Infection Risk in the Rv144 Vaccine TrialSusan Zolla-Pazner, Peter B GilbertPlos One|January 7, 2011
Comparative magnitude of cross-strain conservation of HIV variable loop neutralization epitopesJames Swetnam, Evgeny Shmelkov, Susan Zolla-Pazner, et al.The Lancet. HIV|May 24, 2021
A tale of four studies: HIV vaccine immunogenicity and efficacy in clinical trialsSusan Zolla-Pazner, Nelson L Michael, Jerome H KimJournal of Virology|February 15, 2013
Antibody-DEPENDENT, FcγRI-mediated neutralization of HIV-1 in TZM-bl cells occurs independently of phagocytosisLautaro G Perez, Susan Zolla-Pazner, David C MontefioriAIDS Research and Human Retroviruses|July 13, 2006
Distinct sequence patterns characterize the V3 region of HIV type 1 gp120 from subtypes A and CKlára Felsövályi, Arthur Nádas, Susan Zolla-Pazner, et al.Frontiers in Immunology|May 20, 2022
Impact of IgG Isotype on the Induction of Antibody-Dependent Cellular Phagocytosis of HIV by Human Milk LeukocytesAlisa Fox, Xiaomei Liu, Susan Zolla-Pazner, et al.Pageof 17